CEO Daniel Vitt enters new employment agreement for temporary US relocation; board role at Immunic AG paused

IMMUNIC, INC.

Employment agreement effective Dec 16, 2024 for CEO's planned <1 year US relocation; board role at Immunic AG suspended.
Base salary $610,000/yr, target annual bonus 55% of salary, eligible for equity awards under existing plan.
Monthly housing reimbursement up to $100,000 during US relocation, plus standard benefits and COBRA continuation.
Severance: 12 months' salary on non-cause/good reason termination (outside change-of-control) if release executed; 18 months if within change-of-control period.
Suspension agreement dated Dec 18, 2024 pauses Immunic AG service agreement until reappointment; no remuneration during suspension.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.